Cancer biomarkers.

Molecular Oncology
N Lynn Henry, Daniel F Hayes

Abstract

Biomarkers have many potential applications in oncology, including risk assessment, screening, differential diagnosis, determination of prognosis, prediction of response to treatment, and monitoring of progression of disease. Because of the critical role that biomarkers play at all stages of disease, it is important that they undergo rigorous evaluation, including analytical validation, clinical validation, and assessment of clinical utility, prior to incorporation into routine clinical care. In this review we address key steps in the development of biomarkers, including ways to avoid introducing bias and guidelines to follow when reporting results of biomarker studies.

References

Oct 16, 1996·Journal of the National Cancer Institute·D F HayesR J Winn
Feb 28, 2002·Lancet·Emanuel F PetricoinLance A Liotta
May 25, 2002·The New England Journal of Medicine·Noah D KauffKenneth Offit
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Jan 1, 2003·Clinical Chemistry·Patrick M BossuytUNKNOWN Standards for Reporting of Diagnostic Accuracy
Jan 7, 2003·Annals of Internal Medicine·Patrick M BossuytUNKNOWN Standards for Reporting of Diagnostic Accuracy
Aug 20, 2004·The New England Journal of Medicine·Massimo CristofanilliDaniel F Hayes
Dec 14, 2004·The New England Journal of Medicine·Soonmyung PaikNorman Wolmark
Mar 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laura J van't VeerDaniel F Hayes
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel J SargentLaurence Collette
Jul 27, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lisa M McShaneUNKNOWN Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Aug 18, 2005·British Journal of Cancer·L M McShaneUNKNOWN Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartUNKNOWN Herceptin Adjuvant (HERA) Trial Study Team
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Jan 6, 2006·The Journal of Clinical Investigation·Josep VillanuevaPaul Tempst
Oct 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James L KhatcheressianUNKNOWN American Society of Clinical Oncology
Oct 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gershon Y LockerUNKNOWN ASCO
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Dec 23, 2006·Pharmacogenomics·Federico Innocenti, Mark J Ratain
Aug 10, 2007·Nature Biotechnology·Chris F TaylorHenning Hermjakob
Oct 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lyndsay HarrisUNKNOWN American Society of Clinical Oncology
Aug 6, 2008·Annals of Internal Medicine·Kenneth LinUNKNOWN U.S. Preventive Services Task Force
Sep 25, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Steven M TeutschUNKNOWN EGAPP Working Group
Oct 10, 2009·Journal of the National Cancer Institute·Richard M SimonDaniel F Hayes
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David F Ransohoff, Margaret L Gourlay
Jan 16, 2010·Journal of the National Cancer Institute·Boris FreidlinEdward L Korn
Apr 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Elizabeth H HammondAntonio C Wolff
Jun 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy D GilliganUNKNOWN American Society of Clinical Oncology
Sep 3, 2010·JAMA : the Journal of the American Medical Association·Susan M DomchekTimothy R Rebbeck
Oct 5, 2010·Lancet·Gordon J S RustinUNKNOWN EORTC 55955 investigators
Feb 12, 2011·Journal of the National Comprehensive Cancer Network : JNCCN·Robert W CarlsonUNKNOWN National Comprehensive Cancer Network
May 18, 2011·Journal of Proteome Research·Helen M MooreJim Vaught
Jun 3, 2011·JAMA : the Journal of the American Medical Association·John P A Ioannidis, Orestis A Panagiotou
Jul 27, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinUNKNOWN American Society of Clinical Oncology

❮ Previous
Next ❯

Citations

Nov 3, 2012·British Medical Bulletin·Helmout ModjtahediSharadah Essapen
Aug 15, 2013·BMC Medicine·Brian GodmanLars L Gustafsson
Feb 13, 2013·Journal of Nucleic Acids·Yun Min ChangWeihong Tan
Aug 15, 2015·Virchows Archiv : an International Journal of Pathology·S SchmittE Herpel
Nov 11, 2015·Nature Reviews. Clinical Oncology·Kit Man WongS Gail Eckhardt
Feb 16, 2013·Clinics in Chest Medicine·José M Porcel
Nov 7, 2015·Proteomics. Clinical Applications·Parul MittalPeter Hoffmann
Jan 24, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A S ClarkD Mankoff
Dec 22, 2015·Seminars in Nuclear Medicine·David A MankoffDaniel A Pryma
Aug 19, 2015·Critical Reviews in Oncology/hematology·Evelyne MaesGeert Baggerman
Apr 6, 2016·Future Oncology·Giovanna TrecateRosaria Orlandi
Aug 17, 2014·Talanta·Raquel C B MarquesM Begoña González-García
Dec 3, 2014·Clinical Biochemistry·Eric S ChristensonBen H Park
Dec 24, 2014·Bioanalysis·Ilaria Palchetti
May 24, 2016·Ageing Research Reviews·Mantas MatjusaitisAlexandra Stolzing
Jun 22, 2016·Bioanalysis·Isabelle KohlerMartin Giera
Oct 22, 2016·New Biotechnology·Anne Blanchard
Jul 14, 2016·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·N Lynn Henry
Sep 3, 2016·Frontiers in Physiology·Nadiah Abu, Rahman Jamal
Aug 29, 2016·Translational Oncology·Julian BiauMarie Dutreix
Oct 21, 2016·Frontiers in Neurology·Svetlana A DambinovaAlexander A Potapov
Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eliezer M Van AllenMia A Levy
May 26, 2016·Scientific Reports·Olalla Otero-EstévezVicenta Soledad Martínez-Zorzano
Nov 16, 2016·Scientific Reports·Hwayeong CheonJoo-Hiuk Son
Jan 31, 2017·Advanced Materials·Marcel BraendleinRóisín M Owens
Apr 14, 2017·Respiratory Research·Lourdes Cortes-Dericks, Ralph Alexander Schmid
Nov 28, 2015·Chemical Society Reviews·Matthew J BakerGanesh D Sockalingum
Jul 6, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Edgardo Rojas-MancillaRodrigo Ramirez-Tagle
Apr 4, 2018·Statistics in Medicine·Meng Liu, Emily V Dressler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

© 2022 Meta ULC. All rights reserved